Lexaria Bioscience Corp (NQ: LEXX )Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Lexaria Releases Annual Letter from the CEO
January 13, 2023
Lexaria Receives First Granted Patent in Canada
December 29, 2022
Lexaria’s Human Oral Nicotine Study Begins Dosing
December 20, 2022
Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review
December 13, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|